The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of PMV Pharmaceuticals Inc (NASDAQ: PMVP) was $1.44 for the day, up 1.41% from the previous closing price of $1.42. In other words, the price has increased by $1.41 from its previous closing price. On the day, 0.57 million shares were traded. PMVP stock price reached its highest trading level at $1.5 during the session, while it also had its lowest trading level at $1.3684.
Ratios:
Our analysis of PMVP’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 12.52 and its Current Ratio is at 12.52. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
On May 13, 2024, Craig Hallum started tracking the stock assigning a Buy rating and target price of $6.
On April 12, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $5.Jefferies initiated its Buy rating on April 12, 2024, with a $5 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 01 ’25 when Ticktin Robert sold 23,151 shares for $1.06 per share. The transaction valued at 24,651 led to the insider holds 98,695 shares of the business.
Jalota Deepika sold 33,065 shares of PMVP for $35,198 on Jul 01 ’25. The Chief Development Officer now owns 89,959 shares after completing the transaction at $1.06 per share. On Jul 01 ’25, another insider, Carulli Michael, who serves as the Chief Financial Officer of the company, sold 28,249 shares for $1.06 each. As a result, the insider received 30,077 and left with 60,146 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PMVP now has a Market Capitalization of 76306896 and an Enterprise Value of -64947156.
Stock Price History:
The Beta on a monthly basis for PMVP is 1.52, which has changed by -0.09433961 over the last 52 weeks, in comparison to a change of 0.15624678 over the same period for the S&P500. Over the past 52 weeks, PMVP has reached a high of $1.82, while it has fallen to a 52-week low of $0.81. The 50-Day Moving Average of the stock is 8.38%, while the 200-Day Moving Average is calculated to be 11.51%.
Shares Statistics:
PMVP traded an average of 302.20K shares per day over the past three months and 369260 shares per day over the past ten days. A total of 52.99M shares are outstanding, with a floating share count of 44.73M. Insiders hold about 15.59% of the company’s shares, while institutions hold 56.50% stake in the company. Shares short for PMVP as of 1755216000 were 803935 with a Short Ratio of 2.72, compared to 1752537600 on 769976. Therefore, it implies a Short% of Shares Outstanding of 803935 and a Short% of Float of 1.79.
Earnings Estimates
PMV Pharmaceuticals Inc (PMVP) is currently under the scrutiny of 4.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is -$0.42, with high estimates of -$0.4 and low estimates of -$0.45.
Analysts are recommending an EPS of between -$1.54 and -$1.62 for the fiscal current year, implying an average EPS of -$1.57. EPS for the following year is -$1.75, with 3.0 analysts recommending between -$1.65 and -$1.91.
